...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024

Not sure how you turned my buck into a dime?? Or did really think I'd sell a 100k share for buck total - good grief man

 

Share
New Message
Please login to post a reply